Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Golnaar mouthwash is a traditional Iranian herbal formulation derived from the dried flowers of *Punica granatum var. pleniflora* (commonly known as 'Golnaar'). Developed by researchers at Shiraz University of Medical Sciences, this preparation utilizes the male pomegranate plant, which produces flowers but no fruit. The mouthwash is prepared by mixing dried flower powder with vinegar and diluting it with distilled water. It has been primarily evaluated for its efficacy in treating gingivitis, particularly in patients with diabetes mellitus. The therapeutic effects are attributed to high concentrations of tannins and polyphenols, which provide potent antibacterial and anti-inflammatory properties. Clinical trials, including a triple-blind randomized study (NCT02227485), have demonstrated that the formulation is safe and effective, showing comparable results to chlorhexidine without the associated side effect of tooth staining.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Golnaar mouthwash.